Trial Profile
Amyloid PET imaging study for dimenting disorders
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Jan 2021
Price :
$35
*
At a glance
- Drugs Florbetapir F 18 (Primary)
- Indications Dementia
- Focus Diagnostic use
- 07 Jan 2021 Status changed from not yet recruiting to completed.
- 20 Sep 2017 New trial record